News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year20272026202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Four Vall d’Hebron researchers receive Gilead 2024 and 2025 grants 04/06/2026 Vall d'Hebron creates the KIDS group to promote children's participation in research 25/03/2026 Vall d’Hebron develops a model to classify patients with metabolic fatty liver disease 14/11/2025 Eight Vall d’Hebron professionals among the world’s most cited researchers 12/11/2025 More than one hundred patients with locally advanced and borderline resectable cancer 23/08/2024 A clinical trial has led to approval of the first drug for advanced fatty liver disease 26/03/2024 Four Vall d'Hebron researchers among the most cited in 2023 according to Clarivate 15/11/2023 New treatment based on nanoparticles for chronic liver disease 14/11/2023 Four Vall d'Hebron projects selected for the CaixaImpulse Health Innovation programme 17/10/2023 Vall d’Hebron acull una sessió sobre els assaigs clínics en fetge gras no alcohòlicl 24/05/2023 Two Vall d’Hebron research projects get grants from the City Council and the “La Caixa 02/03/2023 Collaborative trial platforms, key in the NASH research 14/11/2022 The Multidisciplinary Committee on Pancreatic Cancer at the National Surgery Congress 11/11/2022 Research on prevention, diagnosis and treatment of adult and childhood cancer 24/09/2022 Vall d’Hebron hosted IMI-2 EU-PEARL work meeting about platforms for clinical trials 17/05/2022 Clinical trial designed to treat locally advanced pancreatic cancer with nanoparticles 18/03/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 RESPONSE, a global phase III clinical trial for primary biliary cholangitis 03/02/2022 Vall d’Hebron, committed to cancer research 23/09/2021 The Multidisciplinary Pancreatic Cancer Committee has already carried out 686 assessments on 305 patients 05/09/2021